Effects of CD14 macrophages and proinflammatory cytokines on chondrogenesis in osteoarthritic synovium-derived stem

Sun Ae Han1, Sahnghoon Lee, Sang Cheol Seong

  • 1Department of Orthopaedic Surgery, Seoul National University College of Medicine , Seoul, South Korea .

Insights

Removing CD14 macrophages improves chondrogenesis in osteoarthritic stem cells. Nuclear factor-κB and C/EBPβ mediate inflammation

Area of Science:

  • Stem cell biology
  • Immunology
  • Osteoarthritis research

Background:

  • Osteoarthritis (OA) is characterized by cartilage degradation.
  • Synovium-derived stem cells (SDSCs) are crucial for cartilage repair.
  • Inflammatory cytokines in OA synovial fluid negatively impact SDSC function.

Purpose of the Study:

  • To investigate the impact of CD14 macrophages and inflammatory cytokines on chondrogenic differentiation of OA SDSCs.
  • To determine the role of nuclear factor-κB (NF-κB) and CCAAT/enhancer-binding protein β (C/EBPβ) in cytokine-induced suppression of chondrogenesis.
  • To evaluate the therapeutic potential of CD14+ macrophage depletion in OA SDSCs.

Main Methods:

  • Analysis of osteoarthritic synovial fluid for inflammatory cytokines (IL-1β, TNF-α, IL-6).
  • Flow cytometry and magnetically activated cell sorting for SDSC characterization and CD14+ cell isolation.
  • Assessment of chondrogenic potential via type II collagen expression (mRNA and protein).
  • Small interfering RNA (siRNA) transfection to knockdown NF-κB and C/EBPβ.

Main Results:

  • A correlation was found between CD14+ cell ratio in OA SDSCs and IL-1β/TNF-α levels in synovial fluid.
  • CD14-negative OA SDSCs exhibited enhanced chondrogenic potential, indicated by higher type II collagen expression.
  • IL-1β and TNF-α significantly inhibited chondrogenic gene expression, an effect reversed by NF-κB and C/EBPβ knockdown.

Conclusions:

  • Depletion of CD14+ macrophages improves the chondrogenic capacity of CD14(high) OA SDSCs.
  • NF-κB (RelA) and C/EBPβ are key mediators of IL-1β-induced suppression of chondrogenic potential in human SDSCs.
  • Targeting CD14+ macrophages and the NF-κB/C/EBPβ pathway may offer therapeutic strategies for osteoarthritis.